 Progression diabetes autoimmune endocrine patients islet cell antibodies screening program serum samples autoimmune serology laboratory patients clinical subclinical autoimmune endocrine manifestations islet cell antibodies ICAs absence overt diabetes development insulin-dependent Twenty-two type follow-up yr mean SE yr probability free type yr first detection ICAs Progression amount ICAs high titers ICAs equal Juvenile Diabetes Foundation units free type yr ICA persistency free type nonpersistent ICA complement-fixing CF -ICAs free type non-CF-ICA coexistence insulin autoantibodies IAAs free type IAA- positive family history relative type free type family history trend diabetes males age relationships number type clinical expression associated autoimmunities family history disorders